Navigation program: comparison of diagnosis-treatment times among breast cancer patients.
Fernanda Felipe Pautasso, Maiara Anchau Floriani, Nicole de Moraes Pertile and 1 others
PMID 42307349WHAT IT FOUND
In all 359 breast cancer patients, nurse navigation did not shorten overall diagnosis-to-treatment time.
Navigated patients waited longer for surgery. When split by insurance, navigated patients had shorter times to any treatment and neoadjuvant treatment.
Key findings
01Across the whole sample, nurse navigation did not significantly reduce time to any treatment or neoadjuvant treatment, but time to surgery was significantly longer in navigated patients.
02Among public-system patients, navigated patients had median 77.0 days from diagnosis to any treatment and 77.0 days to neoadjuvant treatment, compared with 100.5 and 85.5 days for non-navigated patients.
03Among supplementary health insurance patients, navigated patients had median 38.0 days from diagnosis to any treatment and 31.0 days to neoadjuvant treatment, compared with 47.0 and 50.0 days for non-navigated patients.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was observational, so patients were not randomly assigned to navigation, and people who entered the navigation program differed from those who did not. Navigated patients were more likely to be treated through the public system, to have non-white skin color, lower education, stage III or IV disease, and chemotherapy, so these differences may explain some time findings. Only age was matched and only insurance type was used to adjust comparisons, so other factors that affect treatment timing were not controlled. The surgery interval combined surgery performed before and after neoadjuvant treatment, and the database did not record which was which. Some records had negative diagnosis-to-treatment intervals because benign initial pathology was confirmed as cancer after surgery. The study reported time to treatment, not survival, quality of life, adherence, or clinical outcomes. It was done at one hospital in Brazil, with one nurse navigator for the breast cancer pathway, so results may not transfer to other services. The navigation program included several nurse activities, and the study cannot show which component produced any difference.
The easy way to misread this
Do not conclude that nurse navigation caused faster care or shortened overall treatment time. In the whole group, times to any treatment and neoadjuvant treatment were not significantly different, and surgery timing was longer in navigated patients. The study was observational, groups differed, and navigation was a bundle of activities whose separate parts were not tested.